PsilodexMedication × psilocybin
Your list , 0 items
Medication class

Inhalers and psilocybin.

12 records in this group. None has published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.

12Records
0With human data

Also searched as inhaler · my inhaler · rescue inhaler · puffer

01 What the evidence covers

Best evidence available per medication
12No psilocybin data
No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts

02 Each medication

A to Z
  • Albuterol · ProAir, Ventolin, ProventilEvidence: No psilocybin data

    Bronchospasm in reversible obstructive airway disease (such as asthma); Exercise-induced bronchospasm (prevention)

    It raises heart rate, which may add to psilocybin's rise in heart rate.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Albuterol–ipratropium · Combivent, DuoNebEvidence: No psilocybin data

    COPD with bronchospasm needing a second bronchodilator

    Its albuterol can raise heart rate and may add to psilocybin's rise. Inhaled ipratropium is poorly absorbed, so its effects are mostly local.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Beclomethasone (inhaled, nasal) · Qvar RediHaler, QnaslEvidence: No psilocybin data

    Maintenance treatment of asthma (ages 4 and up); Nasal symptoms of seasonal and year-round allergic rhinitis (ages 4 and up)

    This inhaled or nasal steroid has not been studied with psilocybin, and no mechanism linking them has been described.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Budesonide–formoterol · SymbicortEvidence: No psilocybin data

    Asthma (age 6 and older); Chronic obstructive pulmonary disease (COPD) maintenance and reducing flare-ups

    Its formoterol can raise heart rate and blood pressure, which may add to psilocybin's rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Budesonide–glycopyrrolate–formoterol · Breztri AerosphereEvidence: No psilocybin data

    Chronic obstructive pulmonary disease (COPD) maintenance; Asthma maintenance (age 12 and older)

    Its formoterol can raise pulse and blood pressure and may add to psilocybin's rise; its glycopyrrolate blocks acetylcholine.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fluticasone–salmeterol · Advair, Wixela InhubEvidence: No psilocybin data

    Asthma; COPD (chronic obstructive pulmonary disease) maintenance and flare-up reduction

    Its salmeterol can raise pulse and blood pressure, which psilocybin also briefly raises, so effects may add.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fluticasone–umeclidinium–vilanterol · TrelegyEvidence: No psilocybin data

    COPD (chronic obstructive pulmonary disease) maintenance; Asthma maintenance (adults)

    Its vilanterol can raise pulse and blood pressure, which psilocybin also briefly raises, so effects may add.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Fluticasone–vilanterol · BreoEvidence: No psilocybin data

    COPD (chronic obstructive pulmonary disease) maintenance; Asthma maintenance

    Its vilanterol can raise pulse and blood pressure, which psilocybin also briefly raises, so effects may add.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Ipratropium (inhaled, nasal) · Atrovent HFAEvidence: No psilocybin data

    Maintenance treatment of bronchospasm in COPD, including chronic bronchitis and emphysema (inhaled); Runny nose from allergic and nonallergic year-round rhinitis (nasal spray)

    Not studied with psilocybin; little of it reaches the blood, so whole-body effects adding to psilocybin's may be small.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Levalbuterol · Xopenex, Xopenex HFAEvidence: No psilocybin data

    Bronchospasm (airway narrowing) in reversible obstructive airway disease

    It can raise pulse and blood pressure in some people, which may add to psilocybin's usual rise.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Mometasone (inhaled, nasal) · Asmanex HFA, Asmanex Twisthaler, Nasonex 24HREvidence: No psilocybin data

    Maintenance treatment of asthma (ages 5 and up); Nasal allergy symptoms (hay fever and other upper respiratory allergies)

    Not studied with psilocybin; no linking mechanism is described.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

  • Tiotropium · SpirivaEvidence: No psilocybin data

    COPD (chronic obstructive pulmonary disease) maintenance and flare-up reduction; Asthma maintenance (ages 6 and older)

    An inhaled medicine. Not studied with psilocybin; no linking mechanism is described.

    CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final

03 Properties the records flag

Records with each flag
8Raises blood pressure or heart rate
4Anticholinergic
1QT-prolonging

Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.

04 State rules

Official text governs
COColorado · final · checked 2026-10-24

No provision names these medications or this group.

OROregon · final · checked 2026-10-24

No provision names these medications or this group.

NMNew Mexico · pending · checked 2026-10-24

Rules not final; the proposed rules reviewed name no medication in this group.

05 Studies cited in this group

Records citing each
8Halman A, Kong G, Sarris J, Perkins D. Drug–drug interactions involving classic psychedelics: a systematic review. J Psychopharmacol 2024;38(1):3–18.
8Sarparast A, Thomas K, Malcolm B, Stauffer CS. Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review. Psychopharmacology 2022;239(6):1945–1976.

Records reviewed 2026-09-30 to 2026-10-04. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z

AgreementPsilodex

Before you use Psilodex

Check each box to continue.

Your searches, your list and the medications you look up stay in this browser. We can't see them. Privacy · Emergency: 911 · Mental health crisis: call or text 988 · Poison Control: 1-800-222-1222

Terms version 2026-10-25